MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Employing intraoperative microelectrode recordings during "asleep" deep brain stimulation surgery of the globus pallidus internus in Parkinson’s disease

    J.E. Quintero, N.S. Timoney, J.H. Smith, F. McCarron, G.A. Gerhardt, C.G. van Horne (Lexington, KY, USA)

    Objective: To employ a means of implanting DBS leads to the GPi in individuals with Parkinson's disease who are undergoing the surgery under general anesthesia…
  • 2016 International Congress

    Functional motor outcomes after globus pallidus internus deep brain stimulation in Huntington´s disease – A case report

    T.T.C. Capato, R.G. Cury, R. Gimaães, E.T. Fonoff, M.S. Haddad (São Paulo, Brazil)

    Objective: The aim of this study was to analyse the motor outcome before and after 6 month follow-up in a HD patient treated by GPi-DBS.…
  • 2016 International Congress

    Comparison of cognitive and neuropsychological manifestations in patients with progressive supranuclear palsy (Psp) and Parkinson’s disease

    M.U. Kulsum, S.S. Anand, S. Chatterjee, P. Chatterjee, B. Mondal, S. Choudhury, K. Chatterjee, R. Banerjee, S.S. Jha, H. Kumar (Kolkata, India)

    Objective: 1) To compare the cognitive and neuropsychological manifestations between the patients with PSP and PD. 2) To find out the severity of caregivers distress…
  • 2016 International Congress

    Deep brain stimulation may lead to dramatic worsening of slowly progressive multiple system atrophy: A clinico-pathological series and review of the literature

    C. Laurencin, W. Meissner, C. Tranchant, T. Witjas, F. Viallet, P. Damier, T. Danaila, J.L. Houeto, A. Eusebio, S. Thobois (Lyon, France)

    Objective: The aim of the present study is to describe one of the largest series of histologically proven multiple system atrophy (MSA) patients, who underwent…
  • 2016 International Congress

    Is there any relationship between olfactory dysfunction and memory disorder?

    H. Onuma, Y. Kobayashi, A. Kumon, K. Hasegawa (Sagamihara-city, Japan)

    Objective: To clarify the relationship between non-motor symptoms and memory disorder in 160 cases with PD without cognitive decline in our out-patients clinic. Background: Both…
  • 2016 International Congress

    Frequency of GBA1 and LRRK2 G2019S mutations, and body mass index in Ashkenazi Jews

    N. Doan, D. Raymond, R.A. Ortega, J. Ratliff, I. Meijer, J. Squires, S. Buckingham, B. Johannes, A. Vaigast, I. Perera, W.C. Nichols, L. Ozelius, J. Miravite, L. Severt, V. Shanker, N. Lubarr, S. Bressman, R. Saunders-Pullman (New York, NY, USA)

    Objective: To evaluate the frequency and characteristics of parkinsonism and Parkinson's disease (PD) attributable to LRRK2 G2019S and Glucocerebrosidase1 (GBA1) mutations in Ashkenazi Jewish (AJ)…
  • 2016 International Congress

    Risk of movement disorders with antipsychotic drugs in patients with schizophrenia or depressive disorders

    M.V. Rey, L. Molina, B. Recinos, B. Paz, M. Rovelo, F.E. Rodriguez Elias, J. Calderon, A. Arellano, S. Pomata, S. Perez-Lloret, CA-APD Study Team (Buenos Aires, Argentina)

    Objective: To compare the risk of movement disorders with antipsychotic drugs (APDs) in patients suffering from Schizophrenia or Depressive Disorders. Background: APDs are well-known causes…
  • 2016 International Congress

    Magnetic resonance characteristic of Parkinson’s disease based on the presence of cognitive impairment

    F.B. Doniyorova (Tashkent, Uzbekistan)

    Objective: To study the performance of MRI in patients with Parkinson's disease, depending on the stage of the disease. Background: Steadily progressive chronic neurodegenerative disease…
  • 2016 International Congress

    Auditory function and speech discrimination abilities are impaired in progressive supranuclear palsy

    C. Vitale, G. Santangelo, R. Allocca, T. Abbate, S. Peluso, G. De Michele, M. Moccia, M. Picillo, D. Tafuri, P. Barone, M. Cavaliere (Naples, Italy)

    Objective: To find out hearing ability and speech discrimination of progressive supranuclear palsy (PSP) patients, we performed audiological evaluation by means of Pure Tone (PTA)…
  • 2016 International Congress

    Loss of FBXO7 (PARK15) leads to disturbances in proteasomal function and models parkinsonism-like and pyramidal symptoms in mice

    S. Vingill, D. Brockelt, N. Schwedhelm-Domeyer, L. Tatenhorst, S. Goebbels, P. Lingor, K.A. Nave, J. Stegmueller (Goettingen, Germany)

    Objective: To model Parkinsonian-pyramidal syndrome (PARK15) in mice and investigate the impact of loss of F-box only protein 7 (FBXO7) in neurons on proteasomal activity.…
  • « Previous Page
  • 1
  • …
  • 166
  • 167
  • 168
  • 169
  • 170
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • Effect of marijuana on Essential Tremor: A case report
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley